We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Fujifilm Seeks Approval for Avigan as COVID-19 Treatment
Fujifilm Seeks Approval for Avigan as COVID-19 Treatment
Fujifilm has filed for approval of its influenza drug Avigan (favipiravir) in Japan for treatment of COVID-19 patients, after the antiviral showed promise in a phase 3 trial.